Showing 901 - 920 results of 1,303 for search 'Eligible (novel)', query time: 0.14s Refine Results
  1. 901
  2. 902

    Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN Study by Dana V. Rizk, Brad H. Rovin, Hong Zhang, Naoki Kashihara, Bart Maes, Hernán Trimarchi, Vlado Perkovic, Matthias Meier, Dmitrij Kollins, Olympia Papachristofi, Alan Charney, Jonathan Barratt

    Published 2023-05-01
    “…Conclusions: APPLAUSE-IgAN will evaluate the benefits and safety of iptacopan, a novel targeted therapy for IgAN, in reducing complement-mediated kidney damage and thus slowing or preventing disease progression.…”
    Get full text
    Article
  3. 903
  4. 904
  5. 905
  6. 906

    Case Report: Subtotal Lymphoid and Total Marrow Irradiation as Bridge Therapy to CD19-Directed CAR T Cells in a Chemorefractory DLBCL With Leukemic Involvement by Simonetta Saldi, Vincenzo Maria Perriello, Lorenza Falini, Loredana Ruggeri, Christian Fulcheri, Sara Ciardelli, Alessandra Innocente, Stelvio Ballanti, Nicodemo Baffa, Leonardo Flenghi, Antonio Pierini, Cynthia Aristei, Brunangelo Falini

    Published 2022-07-01
    “…This extended radiotherapy approach may be an effective bridging therapy for chemorefractory DLBCL patients eligible for CAR T cells who present with a high tumor burden, including massive BM involvement associated with leukemic involvement. …”
    Get full text
    Article
  7. 907

    Role of Chinese Acupuncture in the Treatment for Chemotherapy-Induced Cognitive Impairment in Older Patients With Cancer: Protocol for a Randomized Controlled Trial by Sunyan Zhao, Jing Zhang, Haijun Wan, Chenjie Tao, Meng Hu, Wei Liang, Zhi Xu, Bingguo Xu, Jiaying Zhang, Guoxin Wang, Ping Li, Guangmei Lyu, Yongling Gong

    Published 2024-02-01
    “…ObjectiveOur study aims to directly contribute to the existing knowledge of this novel Chinese medicine mode in older patients with cancer enrolled at the Department of Oncology/Chinese Medicine, Nanjing First Hospital, China, thereby establishing the basis for further research. …”
    Get full text
    Article
  8. 908

    The SCIDOTS Project: evidence of benefits of an integrated tobacco cessation intervention in tuberculosis care on treatment outcomes by Awaisu, Ahmed, Nik Mohamed, Mohamad Haniki, Mohamad Noordin, Noorliza, Abd Aziz, Noorizan, Syed Sulaiman, Syed Azhar, Muttalif, Abdul Razak, Ahmad Mahayiddin, Aziah

    Published 2011
    “…Eleven sessions of individualized cognitive behavioral therapy with or without nicotine replacement therapy were provided to each participant in the integrated intervention group. The impacts of the novel approach on biochemically validated smoking cessation and TB treatment outcomes were measured periodically as appropriate. …”
    Get full text
    Article
  9. 909

    Muscle synergies for evaluating upper limb in clinical applications: A systematic review by Kunkun Zhao, Zhisheng Zhang, Haiying Wen, Bin Liu, Jianqing Li, Andrea d’Avella, Alessandro Scano

    Published 2023-05-01
    “…Most of the studies report that analyses on synergy number, structure, and activations provide novel insights on the physiopathology of motor control that cannot be gained with standard clinical assessments, and suggest that muscle synergies may be useful to personalize therapies and to develop new therapeutic strategies. …”
    Get full text
    Article
  10. 910
  11. 911

    AlcoChange: A digital therapeutic for patients with alcohol-related liver disease by Gautam Mehta, Su Lin, Aida Nadar, Bharadwaj PV, Ravi Kumar, Anu Balaji, Stewart Macdonald, Mohammed F. Sheikh, MohammadMahdi Saeidinejad, Shiv-Raj Sharma, Ji J. King, Rajeshwar P. Mookerjee, Lorraine McDonagh, Sarah A. Afuwape, Kevin Moore, Rajiv Jalan

    Published 2024-04-01
    “…The aim of this project was to develop and clinically test AlcoChange, a novel digital therapeutic for ARLD. Methods: AlcoChange was developed using validated behaviour change techniques and a digital alcohol breathalyser. …”
    Get full text
    Article
  12. 912

    The influence of shunting left/right portal vein branch on post-TIPS hepatic encephalopathy: a study protocol for multicenter randomized blinded controlled trial by Jingqin Ma, Jianjun Luo, Wen Zhang, Yongjie Zhou, Zihan Zhang, Minjie Yang, Zhiquan Zhuang, Li Ma, Jiaze Yu, Xin Zhou, Zhiping Yan

    Published 2023-05-01
    “…The safety and stability of TIPS have been greatly improved due to the improvements of related technologies and the emergence of various novel devices, but the incidence of hepatic encephalopathy (HE) after shunting (10–50%) hindered the widespread use of TIPS. …”
    Get full text
    Article
  13. 913
  14. 914
  15. 915

    Clinicopathological and prognostic significance of long noncoding RNA MALAT1 in human cancers: a review and meta-analysis by Juan Li, Zhigang Cui, Hang Li, Xiaoting Lv, Min Gao, Zitai Yang, Yanhong Bi, Ziwei Zhang, Shengli Wang, Baosen Zhou, Zhihua Yin

    Published 2018-08-01
    “…Conclusions The present findings demonstrated that MALAT1 may be a novel biomarker for predicting survival outcome, lymph node metastasis and distant metastasis.…”
    Get full text
    Article
  16. 916
  17. 917

    Digital Education for Health Professionals: An Evidence Map, Conceptual Framework, and Research Agenda by Lorainne Tudor Car, Selina Poon, Bhone Myint Kyaw, David A Cook, Victoria Ward, Rifat Atun, Azeem Majeed, Jamie Johnston, Rianne M J J van der Kleij, Mariam Molokhia, Florian V Wangenheim, Martin Lupton, Niels Chavannes, Onyema Ajuebor, Charles G Prober, Josip Car

    Published 2022-03-01
    “…ResultsWe identified 77 eligible systematic reviews. All of them included experimental studies and evaluated the effectiveness of digital education interventions in different health care disciplines or different digital education modalities. …”
    Get full text
    Article
  18. 918

    A visualized model for identifying optimal candidates for aggressive locoregional surgical treatment in patients with bone metastases from breast cancer by Yuexin Tong, Shaoqing Xu, Liming Jiang, Chengliang Zhao, Dongxu Zhao

    Published 2023-10-01
    “…Besides, there was no difference in survival between the estimated sur-non-benefit subset and the non-surgery group.ConclusionOur study further confirmed the significance of local surgery in BC patients with BM and proposed a novel tool to identify optimal surgical candidates.…”
    Get full text
    Article
  19. 919
  20. 920

    Evaluation of an innovative mHealth-based integrated modality for smoking cessation in Chinese smokers: protocol for a randomized controlled trial by Shuilian Chu, Lin Feng, Yingting Zuo, Hang Jing, Di Zhang, Zhaohui Tong, Ju Shi, Haomiao Ma, Zhijin Zhang, Lirong Liang

    Published 2023-03-01
    “…As part of our efforts in smoking cessation, we developed a novel behavioral intervention delivery modality for smoking cessation that integrated three interventions using the WeChat app, called the “Way to Quit” modality (WQ modality). …”
    Get full text
    Article